224 related articles for article (PubMed ID: 15581976)
1. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis.
Ali SH; O'Donnell AL; Balu D; Pohl MB; Seyler MJ; Mohamed S; Mousa S; Dandona P
Cancer Res; 2000 Dec; 60(24):7094-8. PubMed ID: 11156416
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
Taylor AH; al-Azzawi F; Pringle JH; Bell SC
Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
[TBL] [Abstract][Full Text] [Related]
5. Vascular proliferation is important for clinical progress of endometrial cancer.
Stefansson IM; Salvesen HB; Akslen LA
Cancer Res; 2006 Mar; 66(6):3303-9. PubMed ID: 16540684
[TBL] [Abstract][Full Text] [Related]
6. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study of membrane estrogen receptor expression in endometrial carcinoma cells].
Wang ZQ; Wang JL; Wei LH; Zhao D; Gao M; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):471-5. PubMed ID: 17083814
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
Boggess JF; Zhou C; Bae-Jump VL; Gehrig PA; Whang YE
Gynecol Oncol; 2006 Nov; 103(2):417-24. PubMed ID: 16690106
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
Du XL; Jiang T; Sheng XG; Gao R; Li QS
Gynecol Oncol; 2009 Dec; 115(3):371-6. PubMed ID: 19783287
[TBL] [Abstract][Full Text] [Related]
11. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
12. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
13. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
Giavazzi R; Giuliani R; Coltrini D; Bani MR; Ferri C; Sennino B; Tosatti MP; Stoppacciaro A; Presta M
Cancer Res; 2001 Jan; 61(1):309-17. PubMed ID: 11196179
[TBL] [Abstract][Full Text] [Related]
14. A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells.
Akahane M; Akahane T; Shah A; Okajima E; Thorgeirsson UP
Anticancer Res; 2005; 25(2A):701-7. PubMed ID: 15868899
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa.
Bondza PK; Metz CN; Akoum A
J Reprod Immunol; 2008 Apr; 77(2):142-51. PubMed ID: 17854909
[TBL] [Abstract][Full Text] [Related]
16. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
17. SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells.
Zang XP; Pento JT
Anticancer Res; 2008; 28(5A):2733-5. PubMed ID: 19035303
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
19. Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3.
Koduri S; Goldhar AS; Vonderhaar BK
Breast Cancer Res Treat; 2006 Jan; 95(1):37-43. PubMed ID: 16267616
[TBL] [Abstract][Full Text] [Related]
20. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
